UGent spin-off Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial
(03-10-2022) This trial is designed to evaluate the longer-term stability of Indigo’s continuous multi-metabolite (‘CMM’) device.
(03-10-2022) This trial is designed to evaluate the longer-term stability of Indigo’s continuous multi-metabolite (‘CMM’) device.